Teratogen update: Fetal effects after in utero exposure to coumarins Overview of cases, follow‐up findings, and pathogenesis
2002; Wiley; Volume: 66; Issue: 3 Linguagem: Inglês
10.1002/tera.10054
ISSN2472-1727
AutoresDieneke van Driel, Judit Wesseling, Pieter J.J. Sauer, B. C. L. Touwen, E. van der Veer, H. S. A. Heymans,
Tópico(s)Pesticide Exposure and Toxicity
ResumoTeratologyVolume 66, Issue 3 p. 127-140 Teratogen UpdateFree Access Teratogen update: Fetal effects after in utero exposure to coumarins Overview of cases, follow-up findings, and pathogenesis Dieneke Van Driel, Corresponding Author Dieneke Van Driel [email protected] Department of Pediatrics, Beatrix Children's Hospital, University Hospital Groningen, Groningen, The NetherlandsDepartment of Pediatrics, Beatrix Children's Hospital, University Hospital Groningen, PO Box 30.001, 9700 RB Groningen, The NetherlandsSearch for more papers by this authorJudit Wesseling, Judit Wesseling Department of Pediatrics, Beatrix Children's Hospital, University Hospital Groningen, Groningen, The NetherlandsSearch for more papers by this authorPieter J.J. Sauer, Pieter J.J. Sauer Department of Pediatrics, Beatrix Children's Hospital, University Hospital Groningen, Groningen, The NetherlandsSearch for more papers by this authorBert C.L. Touwen, Bert C.L. Touwen Department of Medical Physiology Section Developmental Neurology, University of Groningen, Groningen, The NetherlandsSearch for more papers by this authorEveline Van Der Veer, Eveline Van Der Veer Pathology and Laboratory Medicine, University Hospital Groningen, Groningen, The NetherlandsSearch for more papers by this authorHugo S.A. Heymans, Hugo S.A. Heymans Department of Pediatrics, Emma Children's Hospital, Academic Medical Center, Amsterdam, The NetherlandsSearch for more papers by this author Dieneke Van Driel, Corresponding Author Dieneke Van Driel [email protected] Department of Pediatrics, Beatrix Children's Hospital, University Hospital Groningen, Groningen, The NetherlandsDepartment of Pediatrics, Beatrix Children's Hospital, University Hospital Groningen, PO Box 30.001, 9700 RB Groningen, The NetherlandsSearch for more papers by this authorJudit Wesseling, Judit Wesseling Department of Pediatrics, Beatrix Children's Hospital, University Hospital Groningen, Groningen, The NetherlandsSearch for more papers by this authorPieter J.J. Sauer, Pieter J.J. Sauer Department of Pediatrics, Beatrix Children's Hospital, University Hospital Groningen, Groningen, The NetherlandsSearch for more papers by this authorBert C.L. Touwen, Bert C.L. Touwen Department of Medical Physiology Section Developmental Neurology, University of Groningen, Groningen, The NetherlandsSearch for more papers by this authorEveline Van Der Veer, Eveline Van Der Veer Pathology and Laboratory Medicine, University Hospital Groningen, Groningen, The NetherlandsSearch for more papers by this authorHugo S.A. Heymans, Hugo S.A. Heymans Department of Pediatrics, Emma Children's Hospital, Academic Medical Center, Amsterdam, The NetherlandsSearch for more papers by this author First published: 13 August 2002 https://doi.org/10.1002/tera.10054Citations: 95AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat LITERATURE CITED Abbott A, Sibert JR, Weaver JB. 1977. Chondrodysplasia punctata and maternal warfarin treatment. BMJ 1: 1639–1640. 10.1136/bmj.1.6077.1639 CASPubMedWeb of Science®Google Scholar Baillie M, Allen D, Elkington AR. 1980. The congenital warfarin syndrome: a case report. Br J Ophthalmol 64: 633–635. 10.1136/bjo.64.8.633 CASPubMedWeb of Science®Google Scholar Balde MD, Breitbach GP, Wettstein A, Hoffmann W, Bastert G. 1988. Fallotsche Tetralogie nach Cumarineinnahme in der Fruhschwangerschaft-eine Embryopathie? Geburtsh u Frauenheilk 48: 182–183. 10.1055/s-2008-1035721 CASPubMedWeb of Science®Google Scholar Barker DP, Konje JC, Richardson JA. 1994. Warfarin embryopathy with dextrocardia and situs inversus. Acta Paediatr 83: 411. 10.1111/j.1651-2227.1994.tb18130.x CASPubMedWeb of Science®Google Scholar Barr M, Burdi AR. 1976. Warfarin-associated embryopathy in a 17-week-old abortus. Teratology 14: 129–134. 10.1002/tera.1420140203 PubMedWeb of Science®Google Scholar Becker MH, Genieser NB, Finegold M, Miranda D, Spackman T. 1975. Chondrodysplasia Punctata. Is maternal warfarin therapy a factor? Am J Dis Child 129: 356–359. 10.1001/archpedi.1975.02120400056013 CASPubMedWeb of Science®Google Scholar Bick D, Curry CJR, McGill JR, Schorderet DF, Bux RC, Moore CM. 1989. Male infant with ichthyosis, Kallmann syndrome, chondrodysplasia punctata, and an Xp chromosome deletion. Am J Med Genet 33: 100–107. 10.1002/ajmg.1320330114 CASPubMedWeb of Science®Google Scholar Bleyer WA, Hakami N, Shepard TH. 1971. The development of hemostasis in the human fetus and newborn infant. J Pediatr 79: 838–853. 10.1016/S0022-3476(71)80405-5 CASPubMedWeb of Science®Google Scholar Born D, Martinez EE, Almeida PAM, Santos DV, Carvalho ACC, Moron AF, Miyasaki CH, Moraes SD, Ambrose JA. 1992. Pregnancy in patients with prosthetic heart valves: the effects of anticoagulation on mother, fetus, and neonate. Am Heart J 124: 413–417. 10.1016/0002-8703(92)90606-V CASPubMedWeb of Science®Google Scholar Carlson B. 1999. Developmental disorders: causes, mechanisms, and patterns. In: B Copland, L Caldwell, editors. Human embryology and developmental biology. 2nd Ed. St. Louis: Mosby. p 128–145. Google Scholar Carson M, Reid M. 1976. Warfarin and fetal abnormality. Lancet 1: 1127. 10.1016/S0140-6736(76)99009-7 Web of Science®Google Scholar Caruso A, De Carolis S, Ferrazzani S, Paradisi G, Pomini F, Pompei A. 1993. Pregnancy outcome in women with cardiac valve prosthesis. Eur J Obstet Gynecol 54: 7–11. 10.1016/0028-2243(94)90074-4 Web of Science®Google Scholar Chen WWC, Sing Chan C, Kei Lee P, Wang RYC, Wong VCW. 1982. Pregnancy in patients with prosthetic heart valves: an experience with 45 pregnancies. Q J Med 203: 358–365. Google Scholar Chong MKB, Harvey D, De Swiet M. 1984. Follow-up study of children whose mothers were treated with warfarin during pregnancy. Br J Obstet Gynaecol 91: 1070–1073. 10.1111/j.1471-0528.1984.tb15077.x CASPubMedWeb of Science®Google Scholar Cotrufo M, De Luca TSL, Calabro R, Mastrogiovanni G, Lama D. 1991. Coumarin anticoagulation during pregnancy in patients with mechanical valve prostheses. Eur J Cardiothorac Surg 5: 300–305. 10.1016/1010-7940(91)90039-M CASPubMedWeb of Science®Google Scholar Cox DR, Martin L, Hall BD. 1977. Asplenia syndrome after fetal exposure to warfarin. Lancet 1: 1134. 10.1016/S0140-6736(77)90584-0 Google Scholar Curtin T, Mulhern B. 1980. Foetal warfarin syndrome. Ir Med J 73: 393–394. CASPubMedWeb of Science®Google Scholar Daniele A, Parenti G, D'Addio M, Andria G, Ballabio A, Meroni G. 1998. Biochemical characterization of arylsulfatase E and functional analysis of mutations found in patients with X-linked chondrodysplasia punctata. Am J Hum Genet 62: 562–572. 10.1086/301746 CASPubMedWeb of Science®Google Scholar De Boer-van den Berg MAG, Thijssen HHW, Vermeer C. 1986. The in vivo effects of acenocoumarol, phenprocoumon and warfarin on vitamin K epoxide reductase and vitamin K-dependent carboxylase in various tissues of the rat. Biochim Biophys Acta 884: 150–157. 10.1016/0304-4165(86)90238-2 CASPubMedWeb of Science®Google Scholar De Vries TW, Van der Veer E, Heymans HSA. 1993. Warfarin embryopathy: patient, possibility, pathogenesis and prognosis. Br J Obstet Gynaecol 100: 869–871. 10.1111/j.1471-0528.1993.tb14322.x CASPubMedWeb of Science®Google Scholar DiSaia PJ. 1966. Pregnancy and delivery of a patient with a Starr-Edwards mitral valve prosthesis. Obstet Gynecol 28: 469–472. Web of Science®Google Scholar Feteih R, Tassinari MS, Lian JB. 1990. Effect of sodium warfarin on vitamin K-dependent proteins and skeletal development in the rat fetus. J Bone Miner Res 5: 885–894. 10.1002/jbmr.5650050813 CASPubMedWeb of Science®Google Scholar Fourie DT, Hay IT. 1975. Warfarin as a possible teratogen. S Afr Med J 49: 2081–2083. CASPubMedWeb of Science®Google Scholar Franco B, Meroni G, Parenti G, Levilliers J, Bernard L, Gebbia M, Cox L, Maroteaux P, Sheffield L, Rappold G, Andria G, Petit C, Ballabio A. 1995. A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy. Cell 81: 15–25. 10.1016/0092-8674(95)90367-4 CASPubMedWeb of Science®Google Scholar Freude S, Pabinger-Fasching I, Kozel-Lachmann D, Braun F, Pollak A. 1991. Warfarin-embryopathie bei mütterlicher coumarin-therapie wegen protein-S-mangels. Pädiatrie und Pädologie 26: 239–241. CASPubMedGoogle Scholar Gärtner B, Seifert CB, Michalk DV, Roth B. 1993. Phenprocoumon therapy during pregnancy: case report and comparison of the teratogenic risk of different coumarin derivatives. Z Geburtsh u Perinat 197: 262–265. CASPubMedWeb of Science®Google Scholar Hall BD. 1989. Warfarin embryopathy and urinary tract anomalies: possible new association. Am J Med Genet 34: 292–293. 10.1002/ajmg.1320340234 CASPubMedWeb of Science®Google Scholar Hall JG, Pauli RM, Wilson KM. 1980. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68: 122–140. 10.1016/0002-9343(80)90181-3 CASPubMedWeb of Science®Google Scholar Harrod JE, Sherrod PS. 1981. Warfarin embryopathy in siblings. Obstet Gynecol 57: 673–676. CASPubMedWeb of Science®Google Scholar Holzgreve W, Carey JC, Hall BD. 1976. Warfarin-induced fetal abnormalities. Lancet 914–915. 10.1016/S0140-6736(76)90587-0 CASPubMedWeb of Science®Google Scholar Hosenfeld D, Wiedeman HR. 1989. Chondrodysplasia punctata in an adult recognized as vitamin K antagonist embryopathy. Clin Genet 35: 376–381. 10.1111/j.1399-0004.1989.tb02957.x CASPubMedWeb of Science®Google Scholar Howe AM, Lipson AH, De Silva M, Ouvrier R, Webster WS. 1997. Severe cervical dysplasia and nasal cartilage calcification following prenatal warfarin exposure. Am J Med Genet 71: 391–396. 10.1002/(SICI)1096-8628(19970905)71:4 3.0.CO;2-X CASPubMedWeb of Science®Google Scholar Howe AM, Webster WS. 1992. The warfarin embryopathy: a rat model showing maxillonasal hypoplasia and other skeletal disturbances. Teratology 46: 379–390. 10.1002/tera.1420460408 CASPubMedWeb of Science®Google Scholar Howe AM, Webster WS. 1994. Vitamin K: its essential role in craniofacial development. A review of the literature regarding vitamin K and craniofacial development. Aust Dent J 39: 88–92. 10.1111/j.1834-7819.1994.tb01379.x CASPubMedWeb of Science®Google Scholar Ikonen E, Merikallio E, Osterlund K, Seppala M. 1970. Mitral valve prosthesis, warfarin anticoagulation, and pregnancy. Lancet 12: 1252. 10.1016/S0140-6736(70)92210-5 Google Scholar Iturbe-Alessio I, Del Carmen Fonseca M, Mutchinik O, Angel Santos M, Zajarias A, Salazar E. 1986. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 315: 1390–1393. 10.1056/NEJM198611273152205 CASPubMedWeb of Science®Google Scholar Kaplan LC. 1985. Congenital Dandy-Walker malformation associated with first trimester warfarin: a case report and literature review. Teratology 32: 333–337. 10.1002/tera.1420320302 CASPubMedWeb of Science®Google Scholar Kaplan LC, Anderson GG, Ring BA. 1982. Congenital hydrocephalus and Dandy-Walker malformation associated with warfarin use during pregnancy. Birth Defects Orig Artic Ser 18: 79–83. CASPubMedWeb of Science®Google Scholar Kerber IJ, Warr OS, Richardson C. 1968. Pregnancy in a patient with a prosthetic mitral valve. JAMA 203: 157–159. Web of Science®Google Scholar Kinney HC, Karthigasan J, Boenshteyn NI, Flax JD, Kirschner DA. 1994. Myelination in the developing human brain: biochemical correlates. Neurochem Res 19: 983–996. 10.1007/BF00968708 CASPubMedWeb of Science®Google Scholar Kreyberg Normann E, Stray-Pedersen B. 1989. Warfarin-induced fetal diaphragmatic hernia. Case report. Br J Obstet Gynaecol 96: 729–730. 10.1111/j.1471-0528.1989.tb03291.x PubMedWeb of Science®Google Scholar Lamontagne JM, Leclerc JE, Carrier C, Bureau M. 1983. Warfarin embryopathy—a case report. J Otolaryngol 13: 127–129. Web of Science®Google Scholar Lapiedra OJ, Bernal JM, Ninot S, Gonzalez I, Pastor E, Miralles PJ. 1986. Open heart surgery for thrombosis of a prosthetic mitral valve during pregnancy. Fetal hydrocephalus. J Cardiovasc Surg 27: 217–220. CASPubMedWeb of Science®Google Scholar Larrea JL, Nunez L, Reque JA, Gil Aguado M, Matorras R, Minguez JA. 1983. Pregnancy and mechanical valve prosthesis: a high-risk situation for the mother and the fetus. Ann Thorac Surg 36: 459–463. 10.1016/S0003-4975(10)60488-2 CASPubMedWeb of Science®Google Scholar Lecuru F, Desnos M, Taurelle R. 1996. Anticoagulant therapy in pregnancy. Report of 54 cases. Acta Obstet Gynecol Scand 75: 217–221. 10.3109/00016349609047090 CASPubMedWeb of Science®Google Scholar Lee PK, Wang R, Chow J, Cheung KL, Wong VCW, Chan TK. 1986. Combined use of warfarin and adjusted subcutaneous heparin during pregnancy in patients with an artificial heart valve. J Am Coll Cardiol 8: 221–224. 10.1016/S0735-1097(86)80116-4 CASPubMedWeb of Science®Google Scholar Manfioletti G, Brancolini C, Avanzi G. 1993. The protein encoded by a growth-arrest-specific gene (GAS6) is a new member of the vitamin K-dependent proteins related to protein S, a negative co-regulator in the blood coagulation cascade. Mol Cell Biol 13: 4976–4985. 10.1128/MCB.13.8.4976 CASPubMedWeb of Science®Google Scholar Mason JDT, Jardine A, Gibbin KP. 1992. Foetal warfarin syndrome-a complex airway problem. Case report and review of the literature. J Laryngol Otol 106: 1098–1099. 10.1017/S0022215100121887 CASPubMedWeb of Science®Google Scholar Matorras R, Reque JA, Usandizaga JA, Minguez JA, Larrea JL, Nunez L. 1985. Prosthetic heart valve and pregnancy. Gynecol Obstet Invest 19: 21–31. 10.1159/000299004 CASPubMedWeb of Science®Google Scholar O'Neill H, Blake S, Sugrue D, MacDonald D. 1982. Problems in the management of patients with artificial valves during pregnancy. Br J Obstet Gynaecol 89: 940–943. 10.1111/j.1471-0528.1982.tb05062.x CASPubMedWeb of Science®Google Scholar Olthof E, De Vries TW, Touwen BCL, Smrkowsky M, Geven-Boere LM, Heymans HSA, van der Veer E. 1994. Late neurological, cognitive and behavioral sequelae of prenatal exposure to coumarins: a pilot study. Early Hum Dev 38: 97–109. 10.1016/0378-3782(94)90221-6 CASPubMedWeb of Science®Google Scholar Pati S, Helmbrecht GD. 1994. Congenital schizencephaly associated with in utero warfarin exposure. Reprod Toxicol 8: 115–120. 10.1016/0890-6238(94)90018-3 CASPubMedWeb of Science®Google Scholar Pauli RM, Madden JD, Kranzler KJ, Culpepper W, Port R. 1976. Warfarin therapy initiated during pregnancy and phenotypic chondrodysplasia punctata. J Pediatr 88: 506–508. 10.1016/S0022-3476(76)80281-8 CASPubMedWeb of Science®Google Scholar Pauli RM, Lian JB, Mosher DF, Suttie JW. 1987. Association of congenital deficiency of multiple Vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: clues to the mechanism of teratogenecity of coumarin derivatives. Am J Hum Genet 41: 566–583. CASPubMedWeb of Science®Google Scholar Pawlow I, Pawlow V. 1985. Kumarin-embryopathie. Z Klin Med 40: 885–888. Web of Science®Google Scholar Pettifor JM, Benson R. 1975. Congenital malformations associated with the administration of oral anticoagulants during pregnancy. J Pediatr 86: 459–462. 10.1016/S0022-3476(75)80986-3 PubMedWeb of Science®Google Scholar Price PA, Williamson MK, Haba T, Dell RB, Jee WSS. 1982. Excessive mineralization with growth plate closure in rats on chronic warfarin treatment. Proc Natl Acad Sci USA 79: 7734–7738. 10.1073/pnas.79.24.7734 CASPubMedWeb of Science®Google Scholar Prieto AL, Weber JL, Tracy S, Heeb MJ, Lai C. 1999. Gas6, a ligand for the receptor protein-tyrosine kinase Tyro-3, is widely expressed in the central nervous system. Brain Res 816: 646–661. 10.1016/S0006-8993(98)01159-7 CASPubMedWeb of Science®Google Scholar Quenneville G, Barton B, McDevitt E, Wright IS. 1959. The use of anticoagulants for thrombophlebitis during pregnancy. Am J Obstet Gynecol 77: 1135–1149. 10.1016/0002-9378(59)90058-4 CASPubMedWeb of Science®Google Scholar Raivio KO, Ikonen E, Saarikoski S. 1977. Fetal risks due to warfarin therapy during pregnancy. Acta Paediatr Scand 66: 735–739. 10.1111/j.1651-2227.1977.tb07981.x CASPubMedWeb of Science®Google Scholar Richman EM, Lahman JE. 1976. Fetal anomalies associated with warfarin therapy initiated shortly prior to conception. J Pediatr 88: 509–510. 10.1016/S0022-3476(76)80282-X CASPubMedWeb of Science®Google Scholar Robinson MJ, Pash J, Grimwade J, Campbel J. 1978. Fetal warfarin syndrome. Med J Aust 1: 157. 10.1136/bmj.1.58.157-b CASPubMedWeb of Science®Google Scholar Ruthnum P, Tolmie JL. 1987. Atypical malformations in an infant exposed to warfarin during the first trimester of pregnancy. Teratology 36: 299–301. 10.1002/tera.1420360305 CASPubMedWeb of Science®Google Scholar Salazar E, Izaguirre R, Verdejo J, Mutchinik O. 1996. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 27: 1698–1703. 10.1016/0735-1097(96)00072-1 CASPubMedWeb of Science®Google Scholar Salazar E, Zajarias A, Gutierrez N, Iturbe I. 1984. The problem of cardiac valve prostheses, anticoagulants and pregnancy. Circulation 70: I169–I177. CASPubMedWeb of Science®Google Scholar Sareli P, England MJ, Berk MR, Marcus RH, Epstein M, Driscoll J, Meyer T, McIntyre J, Van Gelderen C. 1989. Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses. Am J Cardiol 63: 1462–1465. 10.1016/0002-9149(89)90008-8 CASPubMedWeb of Science®Google Scholar Saxena SP, Fan T, Li M, Israels ED, Israels LG. 1997. A novel role for vitamin K1 in a tyrosine phosphorylation cascade during chick embryogenesis. J Clin Invest 99: 602–607. 10.1172/JCI119202 CASPubMedWeb of Science®Google Scholar Sbarouni E, Oakley CM. 1994. Outcome of pregnancy in women with valve prostheses. Br Heart J 71: 196–201. 10.1136/hrt.71.2.196 CASPubMedWeb of Science®Google Scholar Shaul WL, Emery H, Hall JG. 1975. Chondrodysplasia punctata and maternal warfarin use during pregnancy. Am J Dis Child 129: 360–362. CASPubMedWeb of Science®Google Scholar Sherman S, Hall BD. 1976. Warfarin and fetal abnormality. Lancet 1: 692. 10.1016/S0140-6736(76)92804-X CASPubMedWeb of Science®Google Scholar Smith MF, Cameron MD. 1979. Warfarin as teratogen. Lancet 1: 727. 10.1016/S0140-6736(79)91181-4 CASPubMedWeb of Science®Google Scholar Stevenson RE, Burton OM, Ferlauto GJ, Taylor A. 1980. Hazards of oral anticoagulants during pregnancy. JAMA 243: 1549–1551. CASPubMedWeb of Science®Google Scholar Struwe FE, Reinwein H, Stier R. 1984. Coumarin embryopathie. Radiologe 24: 68–71. CASPubMedWeb of Science®Google Scholar Sundaram KS, Fan JH, Engelke JA, Foley AL, Suttie JW, Lev M. 1996. Vitamin K status influences brain sulfatide metabolism in young mice and rats. J Nutr 126: 2746–2751. CASPubMedWeb of Science®Google Scholar Sundaram KS, Lev M. 1988. Warfarin administration reduces synthesis of sulfatides and other sphingolipids in mouse brain. J Lipid Res 29: 1475–1479. CASPubMedWeb of Science®Google Scholar Sundaram KS, Lev M. 1990a. Regulation of sulfotransferase activity by vitamin K in mouse brain. Arch Biochem Biophys 277: 109–113. 10.1016/0003-9861(90)90557-F CASPubMedWeb of Science®Google Scholar Sundaram KS, Lev M. 1990b. Vitamin K and phosphate mediated enhancement of brain sulfotransferase activity. Biochem Biophys Res Com 169: 927–932. 10.1016/0006-291X(90)91982-X CASPubMedWeb of Science®Google Scholar Suri V, Sawhney H, Vasishta K, Renuka T, Grover A. 1999. Pregnancy following cardiac valve replacement surgery. Int J Gynecol Obstet 64: 239–246. 10.1016/S0020-7292(98)00263-X CASPubMedWeb of Science®Google Scholar Takano H, Smith WL, Sato Y, Kao SCS. 1998. Cervical spine abnormalities and instability with myelopathy in warfarin-related chondrodysplasia: 17-year follow-up. Pediatr Radiol 28: 497–499. 10.1007/s002470050394 CASPubMedWeb of Science®Google Scholar Tamburrini O, Bartolomeo-De Iuri A, Di Guglielmo GL. 1987. Chondrodysplasia punctata after warfarin: case report with 18-month follow-up. Pediatr Radiol 17: 323–324. 10.1007/BF02388249 CASPubMedWeb of Science®Google Scholar Tejani N. 1973. Anticoagulant therapy with cardiac valve prosthesis during pregnancy. Obstet Gynecol 42: 785–793. CASPubMedWeb of Science®Google Scholar Tongsong T, Wanapirak C, Piyamongkol W. 1999. Prenatal ultrasonographic findings consistent with fetal warfarin syndrome. J Ultrasound Med 18: 577–580. 10.7863/jum.1999.18.8.577 CASPubMedWeb of Science®Google Scholar Tsaioun KI. 1999. Vitamin K-dependent proteins in the developing and aging nervous system. Nutr Rev 57: 231–240. 10.1111/j.1753-4887.1999.tb06950.x CASPubMedWeb of Science®Google Scholar Van Driel D, Wesseling J, Rosendaal FR, Odink RJ, van der Veer E, Gerver WJ, Geven-Boere LM, Sauer PJJ. 2000. Growth until puberty after in utero exposure to coumarins. Am J Med Genet 95: 438–443. 10.1002/1096-8628(20001218)95:5 3.0.CO;2-Z CASPubMedWeb of Science®Google Scholar Van Driel D, Wesseling J, Sauer PJJ, Van der Veer E, Touwen BCL, Smrkovsky M. 2001. In utero exposure to coumarins and cognition at 8–14 years. Pediatrics 107: 123–129. 10.1542/peds.107.1.123 CASPubMedWeb of Science®Google Scholar Van Driel D, Wesseling J, De Vries TW, Sauer PJJ. Coumarin embryopathy: follow-up of two cases. Eur J Pediatr 161: 231–232. Google Scholar Vanlaeys R, Deroubaix P, Deroubaix G, Lelong M. 1977. Les antivitamines K sont-elles tératogènes? Nouv Press Med 6: 756. Web of Science®Google Scholar Varnum BC, Young E, Elliot G. 1995. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth arrest-specific gene-6. Nature 373: 623–626. 10.1038/373623a0 CASPubMedWeb of Science®Google Scholar Ville Y, Jenkins E, Shearer MJ, Hemley H, Vasey DP, Layton M, Nicolaides KH. 1993. Fetal intraventricular hemorrhage and maternal warfarin. Lancet 341: 1211. 10.1016/0140-6736(93)91037-M CASPubMedWeb of Science®Google Scholar Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. 1999. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 33: 1637–1641. 10.1016/S0735-1097(99)00044-3 CASPubMedWeb of Science®Google Scholar Vitali E, Donatelli F, Quaini E, Groppelli G, Pelligrini A. 1986. Pregnancy in patients with mechanical prosthetic heart valves. J Cardiovasc Surg 27: 221–227. CASPubMedWeb of Science®Google Scholar Warkany J, Bofinger M. 1975. Le rôle de la coumadine dans les malformations congénitales. Med Hyg 33: 1454–1457. Google Scholar Weenink GH, Van Dijk-Wierda CA, Meyboom RHB, Koppe JG, Staalman CR, Treffers PE. 1981. Teratogeen effect van coumarine-derivaten. NTvG 125: 702–706. CASPubMedGoogle Scholar Wellesley D, Moore I, Heard M, Keeton B. 1998. Two cases of warfarin embryopathy: a re-emergence of this condition? Br J Obstet Gynaecol 105: 805–806. 10.1111/j.1471-0528.1998.tb10215.x CASPubMedWeb of Science®Google Scholar Wesseling J, Van Driel D, Smrkovsky M, Van der Veer E, Geven-Boere LM, Sauer PJJ, Touwen BCL. 2001. Neurological outcome in school-age children after in utero exposure to coumarins. Early Hum Dev 63: 83–95. 10.1016/S0378-3782(01)00140-2 CASPubMedWeb of Science®Google Scholar Whitfield MF. 1980. Chondrodysplasia punctata after warfarin in early pregnancy: case report and summary of the literature. Arch Dis Child 55: 139–142. 10.1136/adc.55.2.139 CASPubMedWeb of Science®Google Scholar Wong V, Cheng CH, Chan KC. 1993. Fetal and neonatal outcome of exposure to anticoagulants during pregnancy. Am J Med Genet 45: 17–21. 10.1002/ajmg.1320450107 CASPubMedWeb of Science®Google Scholar Zakzouk MS. 1986. The congenital warfarin syndrome. J Laryngol Otol 100: 215–219. 10.1017/S0022215100099011 CASPubMedWeb of Science®Google Scholar Zipprich KW, Canzler E, Hundsdörfer S. 1987. Zur teratogenen wirkung von kumarinen. Zentralbl Gynäkol 109: 364–368. CASPubMedWeb of Science®Google Scholar Citing Literature Volume66, Issue3September 2002Pages 127-140 ReferencesRelatedInformation
Referência(s)